ES-019

N/A

Report date: 2023/12/28 17:53:19

Base Information

Drug NameES-019
Drug Alias NameES-019ES019
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Programmed death-ligand 1Anti-Signal-regulatory protein alpha
TargetsProgrammed death-ligand 1Signal-regulatory protein alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesElpiscience Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesElpiscience Biopharma LtdAstellas Pharma Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A